Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current Strategies to Modulate Regulatory T Cell Activity in Allergic Inflammation. | Front Immunol | 2022 | 35720406 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation. | Front Immunol | 2022 | 35720402 | PubTator, text mining | PubMed |
| Untangling the Knots of Regulatory T Cell Therapy in Solid Organ Transplantation. | Front Immunol | 2022 | 35720387 | PubTator, text mining | PubMed |
| The Correlation Between Immune Invasion and SARS-COV-2 Entry Protein ADAM17 in Cancer Patients by Bioinformatic Analysis. | Front Immunol | 2022 | 35720350 | PubTator, text mining | PubMed |
| RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma. | Front Mol Biosci | 2022 | 35720121 | PubTator, text mining | PubMed |
| Inflammation-Related LncRNAs Signature for Prognosis and Immune Response Evaluation in Uterine Corpus Endometrial Carcinoma. | Front Oncol | 2022 | 35719911 | PubTator, text mining | PubMed |
| The immunosuppressive role of indoleamine 2, 3-dioxygenase in glioblastoma: mechanism of action and immunotherapeutic strategies. | Med Oncol | 2022 | 35716323 | PubTator, text mining | PubMed |
| iRECIST and atypical patterns of response to immuno-oncology drugs. | J Immunother Cancer | 2022 | 35715004 | PubTator, text mining | PubMed |
| Characterization of multiple soluble immune checkpoints in individuals with different Mycobacterium tuberculosis infection status and dynamic changes during anti-tuberculosis treatment. | BMC Infect Dis | 2022 | 35701741 | PubTator, text mining | PubMed |
| Ursodeoxycholic acid reduces antitumor immunosuppression by inducing CHIP-mediated TGF-β degradation. | Nat Commun | 2022 | 35701426 | PubTator, text mining | PubMed |
| Human CD4+CD25+CD226- Tregs Demonstrate Increased Purity, Lineage Stability, and Suppressive Capacity Versus CD4+CD25+CD127lo/- Tregs for Adoptive Cell Therapy. | Front Immunol | 2022 | 35693814 | PubTator, text mining | PubMed |
| SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma. | Front Genet | 2022 | 35692837 | PubTator, text mining | PubMed |
| Cellular Immunity of Patients with Tuberculosis Combined with Diabetes. | J Immunol Res | 2022 | 35692502 | PubTator, text mining | PubMed |
| Phenotype, Function, and Clinical Significance of CD26+ and CD161+Tregs in Splenic Marginal Zone Lymphoma. | Clin Cancer Res | 2022 | 35686915 | PubTator, text mining | PubMed |
| The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment. | Front Pharmacol | 2022 | 35685630 | PubTator, text mining | PubMed |
| A Prognostic Signature for Clear Cell Renal Cell Carcinoma Based on Ferroptosis-Related lncRNAs and Immune Checkpoints. | Front Genet | 2022 | 35685438 | PubTator, text mining | PubMed |
| Emerging Therapies for Hepatocellular Carcinoma (HCC). | Cancers (Basel) | 2022 | 35681776 | PubTator, text mining | PubMed |
| Coming in from the cold: overcoming the hostile immune microenvironment of medulloblastoma. | Genes Dev | 2022 | 35680424 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals the characteristics of cerebrospinal fluid tumour environment in breast cancer and lung cancer leptomeningeal metastases. | Clin Transl Med | 2022 | 35678121 | PubTator, text mining | PubMed |
| Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint Molecules. | Front Immunol | 2022 | 35677046 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=58